Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
Fractyl Health (Nasdaq: GUTS) will report first quarter 2026 financial results and provide business updates on May 12, 2026 at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Fractyl Health (Nasdaq: GUTS) will report first quarter 2026 financial results and provide business updates on May 12, 2026 at 4:30 p.m. ET. A live webcast and archived replay will be available in the company’s Events section at http://ir.fractyl.com.
CEO Harith Rajagopalan, M.D., Ph.D. will present at the BofA Securities 2026 Health Care Conference on May 14, 2026 at 9:20 a.m. PT (12:20 p.m. ET); that presentation will also be webcast and archived.
Details
News Market Reaction – GUTS
On May 5, the day this news came out, GUTS closed 4.57% below the previous close.
Data tracked by StockTitan Argus for the May 5 session.
Key Figures
- Q1 2026 results date
- May 12, 2026
- Scheduled earnings release and business update
- Earnings call time
- 4:30 p.m. ET
- Start time for Q1 2026 conference call
- Conference date
- May 14, 2026
- BofA Securities 2026 Health Care Conference presentation
- Conference time PT
- 9:20 a.m. PT
- Scheduled BofA conference presentation time
- Conference time ET
- 12:20 p.m. ET
- Eastern Time for BofA conference presentation
Historical Context
-
Q4 and 2025 results with clinical progress and runway into early 2027.
-
Scheduled Q4 and full-year 2025 earnings call and webcast details.
-
Completion of REMAIN-1 pivotal randomization and reiterated Q4 2026 data timing.
-
Positive 6‑month REMAIN‑1 midpoint data for Revita after GLP‑1 discontinuation.
-
Appointment of new CFO to support commercial-stage preparedness.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced that it will report financial results for the first quarter 2026 and provide business updates on Tuesday, May 12, 2026, at 4:30 p.m. ET.
A live webcast of the conference call and presentation can be accessed in the “Events” section of Fractyl Health’s website at http://ir.fractyl.com. The webcast will be archived and available for replay following the live event.
The Company also announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of Fractyl Health, will present at the BofA Securities 2026 Health Care Conference on Thursday, May 14, 2026, at 9:20 a.m. PT (12:20 p.m. ET).
A live webcast of the presentation can be accessed in the “Events” section of Fractyl Health’s website at http://ir.fractyl.com. The webcast will be archived and available for replay following the live event.
About Fractyl Health
Fractyl Health is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes. Our Revita® and Rejuva® candidates are designed to target root causes of metabolic diseases, allowing us to advance metabolic disease treatment from chronic management towards prevention and reversal of disease. Fractyl is headquartered in Burlington, Massachusetts.
Contact
Brian Luque, Head of Investor Relations and Corporate Development
IR@fractyl.com, 951.206.1200
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.